Incident NAFLD (Table 3(a)): FLI remained associated with increased risk for NAFLD when treated as continuous variables and dichotomous variables (OR [95% CI], 3.09 [2.53–3.78] and 1.73 [1.18–2.53]); similarly, ALT remained associated with increased risk for NAFLD when treated as continuous variables and dichotomous variables (OR [95% CI], 1.50 [1.12–2.02] and 1.63 [1.13–2.53], respectively. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.